Olodaterol Oral Inhalation

316 interactions 36 cited references

Also sold as: Striverdi Striverdi® Respimat®

About Olodaterol Oral Inhalation

Olodaterol oral inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Olodaterol oral inhalation is in a class of medicatio… Read the full Olodaterol Oral Inhalation drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 247 Major 57 Moderate

All (316) Contraindicated (12) Major (247) Moderate (57)

Contraindicated

Olodaterol Oral Inhalation Bepridil An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Cisapride Propulsid® Increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Dronedarone Multaq Increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Levoketoconazole Recorlev An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Olodaterol Oral Inhalation Mesoridazine An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Pimozide An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Piperaquine An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Saquinavir An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Sparfloxacin An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Terfenadine An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Thioridazine An increased risk of QT interval prolongation Details Olodaterol Oral Inhalation Ziprasidone Geodon An increased risk of QT interval prolongation Details

Major

Olodaterol Oral Inhalation Acebutolol Sectral® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Adagrasib Krazati An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Albuterol ProAir An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Alfuzosin UroXatral An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Amineptine Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Amiodarone Nexterone An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Amisulpride Barhemsys An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Amitriptyline Elavil An increased risk of QT interval prolongation, an increased risk of ventricular arrhythmias and potentiated cardiovascular effects Details Olodaterol Oral Inhalation Amitriptylinoxide Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Amoxapine Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Amphetamine Dexedrine An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Anagrelide Agrylin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Apomorphine Apokyn An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Apraclonidine An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Arformoterol Brovana An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Aripiprazole Abilify An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Aripiprazole Lauroxil Aristada An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Armodafinil Nuvigil An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Arsenic Trioxide Trisenox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Asenapine Saphris An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Astemizole An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Atazanavir Reyataz An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Atenolol Tenormin Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Atomoxetine Atoncy An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Azithromycin AzaSite An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Bedaquiline Sirturo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Betaxolol Betoptic S Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Bisoprolol Zebeta® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.